References
- Trakarnsanga A, Ithimakin S, Weiser MR. Treatment of locally advanced rectal cancer: controversies and questions. World J Gastroenterol 2012; 18: 5521-32. 10.3748/wjg.v18.i39.552123112544
- Ferrari L, Fichera A Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer. Gastroenterology Report 2015; 3: 277-88. 10.1093/gastro/gov03926290512
- Peeters KC, van de Velde CJH, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients – a Dutch colorectal cancer group study. J Clin Oncol 2005; 23: 6199-206. 10.1200/JCO.2005.14.77916135487
- Guillem JG, Chessin DB, Cohen AM, Shia J, Mazumdar M, Enker W, et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. AnnSurg 2005; 241: 829-36. 10.1097/01.sla.0000161980.46459.9615849519
- García-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003; 46: 298-304. 10.1097/01.DCR.0000054637.75996.DF12626903
- Hughes R, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, et al. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Int J Colorectal Dis 2006; 21: 11-7. https://doi.org/10.1007/s00384-005-0749-y1586460510.1007/s00384-005-0749-y
- Huebner M, Wolff BG, Smyrk TC, Aakre J, Larson DW. Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy. World J Surg 2012; 36: 675-83. 10.1007/s00268-011-1409-822270980
- Kalady MF, de Campos-Lobato LF, Stocchi L, Geisler DP, Dietz D, Lavery IC, et al. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg 2009; 250: 582-9. 10.1097/SLA.0b013e3181b91e6319710605
- Huh JW, Kim HR, Kim YJ. Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer. Dis Colon Rectum 2013; 56: 698-703. 10.1097/DCR.0b013e3182837e5b23652742
- Hermanek P, Merkel S, Hohenberger W. Prognosis of rectal carcinoma after multimodal treatment: ypTNM classification and tumor regression grading are essential. Anticancer Res 2013; 33: 559-66. 10.4143/crt.2015.25423393349
- Kawai K, Ishihara S, Nozawa H, Hata K, Kiyomatsu T, Morikawa T, et al. Prediction of pathological complete response using endoscopic findings and outcomes of patients who underwent watchful waiting after chemoradiotherapy for rectal cancer. Dis Colon Rectum 2017; 60: 368–375. 10.1097/DCR.000000000000074228267003
- Smith FM, Wiland H, Mace A, Pai RK, Kalady MF. Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy. Dis Colon Rectum 2014; 57: 311–315. 10.1097/DCR.0b013e3182a84eba24509452
- Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th edition. New York: John Wiley & Sons; 2009.
- Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorect Dis 1997; 12: 19-23.10.1007/s003840050072
- Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg 2012; 99: 918-28. 10.1002/bjs.870222362002
- Fraser MS, Rao C, Perez RO, Bujko K, Habr-Gama A, Faiz O. Avoiding radical surgery improves early survival in elderly patients with rectal cancer, demonstrating complete clinical response after neoadjuvant therapy: results of a decision-analytic mode. Dis Colon Rectum 2015; 58: 159-171.10.1097/DCR.0000000000000281
- Kuo LJ, Liu MC, Jian JJ, Horng CF, Cheng TI, Chen CM, et al. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 2007; 14: 2766-72. 10.1245/s10434-007-9471-z17551794
- Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002; 45: 895-903. org/10.1007/s10350-004-6325-712130878
- Sprenger T, Rothe H, Conradi CR, Beissbarth T, Kauffels A, Kitz J, et al. Stage-dependent frequency of lymph node metastases in patients with rectal carcinoma after preoperative chemoradiation: results from the CAO/ARO/AIO-94 trial and from a comparative prospective evaluation with extensive pathological workup. Dis Colon Rectum 2016; 59: 377-385. 10.1097/DCR.0000000000000570
- Kong JC, Guerra RG, Warrier SK, Ramsay RG, Heriot AG. Outcome and salvage surgery following “Watch and Wait” for rectal cancer after neoadjuvant therapy: a systematic review. Dis Colon Rectum 2017; 60: 335-345. 10.1097/DCR.000000000000075428177997
- Kim NK, Kim MS, Al-Asari SF. Update and debate issues in surgical treatment of middle and low rectal cancer. J Korean Soc Coloproctol 2012; 28: 230-240. 10.1097/SLA.0b013e31829068c523185702
- Maas M, Beets-Tan RG, Lanbregts DM, Lammering G, Nelemans PJ, Engelen SM, et al. Wait-and-see policy for clinical complete responders after chemoradioation for rectal cancer. J Clin Oncol 2011; 29: 4633-40. 10.1200/JCO.2011.3722067400
- Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 448 patients. J Am Coll Surg 2002; 194: 131-5.10.1016/S1072-7515(01)01159-0
- Chang KH, Smith MJ, McAnena OJ, Aprjanto AS, Dowdall JF. Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision. Int J Colorectal Dis 2012; 27: 1275-83. 10.1007/s00384-012-1440-822395659
- Loos M, Quentmeier P, Schuster T, Nitsche U, Gertler R, Keerl A, et al. Effect of preoperative radio(chemo)therapy on long term functional outcome in rectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol 2013; 20: 1816-28. 10.1245/s10434-012-2827-z23269466